FATE
FATE THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$1.86
+3.91%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 55.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.45x
- Price / sales
- 34.33x
- Price / cash flow
- -2.19x
Enterprise value
- Enterprise value
- $144.8M
- EV / sales
- 22.30x
- EV / EBITDA
- -1.27x
- EV / EBIT
- -1.08x
- Market cap
- $222.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026